[Skip to Content]

Upstate Active Clinical Trials

Study Title:

A Phase III, Randomized, Placebo-controlled, Double-blind, Multi-center, International Study of Durvalumab with Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Patients with unresected Stage I/II, lymph-node negative Non-small Cell Lung Cancer (PACIFIC-4/RTOG-3515)

Upstate Institutional Review Board (IRB) Number:

1387295

Study/Protocol ID:

D9103C00001

Study Phase:

III

Patient Age Group:

Adults

Principal Investigator:

Michael D Mix, MD

What is involved if I participate?

  • Is transportation provided or reimbursed?
    No
  • Is parking provided or reimbursed?
    Yes

Where will the study take place?

Radiation Oncology Oswego, Oneida, and The Hill - SBRT and informed consent
SUNY Upstate Cancer Center - all procedures
Medical Oncology Oswego and Oneida - consent only

Who can I contact for more information?

Name: Erin Bingham
Phone: 315-464-3603
Email: binghame@upstate.edu

Return to Previous Page || Search Again

Top